-
1
-
-
0024458031
-
On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: A randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group
-
Lowenberg B, Zittoun R, Kerkhofs H, Jehn U, Abels J, Debusscher L, et al. On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group. J Clin Oncol 1989;7:1268-74.
-
(1989)
J Clin Oncol
, vol.7
, pp. 1268-1274
-
-
Lowenberg, B.1
Zittoun, R.2
Kerkhofs, H.3
Jehn, U.4
Abels, J.5
Debusscher, L.6
-
2
-
-
0025138479
-
Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly
-
Tilly H, Castaigne S, Bordessoule D, Casassus P, Le Prise PY, Tertian G, et al. Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol 1990;8:272-9.
-
(1990)
J Clin Oncol
, vol.8
, pp. 272-279
-
-
Tilly, H.1
Castaigne, S.2
Bordessoule, D.3
Casassus, P.4
Le Prise, P.Y.5
Tertian, G.6
-
3
-
-
0036862084
-
The difficult problem of acute myeloid leukemia in the older adult
-
Stone RM. The difficult problem of acute myeloid leukemia in the older adult. CA Cancer J Clin 2002;52:363-71.
-
(2002)
CA Cancer J Clin
, vol.52
, pp. 363-371
-
-
Stone, R.M.1
-
4
-
-
34249810897
-
Acute myeloid leukemia and myelodysplastic syndromes in older patients
-
Estey E. Acute myeloid leukemia and myelodysplastic syndromes in older patients. J Clin Oncol 2007;25:1908-15.
-
(2007)
J Clin Oncol
, vol.25
, pp. 1908-1915
-
-
Estey, E.1
-
5
-
-
35048820182
-
Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia
-
Baz R, Rodriguez C, Fu AZ, Jawde RA, Kalaycio M, Advani A, et al. Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia. Cancer 2007;110:1752-9.
-
(2007)
Cancer
, vol.110
, pp. 1752-1759
-
-
Baz, R.1
Rodriguez, C.2
Fu, A.Z.3
Jawde, R.A.4
Kalaycio, M.5
Advani, A.6
-
6
-
-
33644521267
-
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: Predictive prognostic models for outcome
-
Kantarjian H, O'Brien S, Cortes J, Giles F, Faderl S, Jabbour E, et al. Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high-risk myelodysplastic syndrome: predictive prognostic models for outcome. Cancer 2006;106:1090-8.
-
(2006)
Cancer
, vol.106
, pp. 1090-1098
-
-
Kantarjian, H.1
O'Brien, S.2
Cortes, J.3
Giles, F.4
Faderl, S.5
Jabbour, E.6
-
7
-
-
33947499161
-
Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia
-
Etienne A, Esterni B, Charbonnier A, Mozziconacci MJ, Arnoulet C, Coso D, et al. Comorbidity is an independent predictor of complete remission in elderly patients receiving induction chemotherapy for acute myeloid leukemia. Cancer 2007;109:1376-83.
-
(2007)
Cancer
, vol.109
, pp. 1376-1383
-
-
Etienne, A.1
Esterni, B.2
Charbonnier, A.3
Mozziconacci, M.J.4
Arnoulet, C.5
Coso, D.6
-
8
-
-
1542753559
-
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
-
Cheson BD, Bennett JM, Kopecky KJ, Buchner T, Willman CL, Estey EH, et al. Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia. J Clin Oncol 2003;21:4642-9.
-
(2003)
J Clin Oncol
, vol.21
, pp. 4642-4649
-
-
Cheson, B.D.1
Bennett, J.M.2
Kopecky, K.J.3
Buchner, T.4
Willman, C.L.5
Estey, E.H.6
-
9
-
-
34948866783
-
Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
-
Kahl C, Storer BE, Sandmaier BM, Mielcarek M, Maris MB, Blume KG, et al. Relapse risk in patients with malignant diseases given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. Blood 2007;110:2744-8.
-
(2007)
Blood
, vol.110
, pp. 2744-2748
-
-
Kahl, C.1
Storer, B.E.2
Sandmaier, B.M.3
Mielcarek, M.4
Maris, M.B.5
Blume, K.G.6
-
10
-
-
0343045296
-
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy - the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: Final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group
-
Lowenberg B, Suciu S, Archimbaud E, Haak H, Stryckmans P, de Cataldo R, et al. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy - the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group. J Clin Oncol 1998; 16:872-81.
-
(1998)
J Clin Oncol
, vol.16
, pp. 872-881
-
-
Lowenberg, B.1
Suciu, S.2
Archimbaud, E.3
Haak, H.4
Stryckmans, P.5
de Cataldo, R.6
-
11
-
-
0035437132
-
Postremission therapy in older patients with de novo acute myeloid leukemia: A randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine
-
Stone RM, Berg DT, George SL, Dodge RK, Paciucci PA, Schulman PP, et al. Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine. Blood 2001;98:548-53.
-
(2001)
Blood
, vol.98
, pp. 548-553
-
-
Stone, R.M.1
Berg, D.T.2
George, S.L.3
Dodge, R.K.4
Paciucci, P.A.5
Schulman, P.P.6
-
12
-
-
34250157761
-
Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: Results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial
-
Gardin C, Turlure P, Fagot T, Thomas X, Terre C, Contentin N, et al. Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial. Blood 2007;109:5129-35.
-
(2007)
Blood
, vol.109
, pp. 5129-5135
-
-
Gardin, C.1
Turlure, P.2
Fagot, T.3
Thomas, X.4
Terre, C.5
Contentin, N.6
|